16049291

Source:http://linkedlifedata.com/resource/pubmed/id/16049291

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010819, umls-concept:C0019638, umls-concept:C0220825, umls-concept:C0242957, umls-concept:C0302908, umls-concept:C0449438, umls-concept:C0678222, umls-concept:C1332762, umls-concept:C1527178, umls-concept:C1705938, umls-concept:C1707455
pubmed:issue	8
pubmed:dateCreated	2005-7-28
pubmed:abstractText	HER-2 amplification is an important prognostic biomarker and treatment determinant in breast carcinoma.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-10087312, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-10371346, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-10396285, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-10425053, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-10678583, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-11073807, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-11074621, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-11248153, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-11777271, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-12177239, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-12619096, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-12653945, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-12685187, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-1351679, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15080305, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15085752, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15113815, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15220365, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15269154, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15272530, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-15272539, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-1688187, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-3798106, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-7849090, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-8085559, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-8529478, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-9174626, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-9256133, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-9661897, http://linkedlifedata.com/resource/pubmed/commentcorrection/16049291-9915137
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0376601
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0021-9746
pubmed:author	pubmed-author:AbbottCC, pubmed-author:BirembautPP, pubmed-author:CostaBB, pubmed-author:CucheroussetJJ, pubmed-author:Doco-FenzyMM, pubmed-author:DurlachAA, pubmed-author:DuvalII, pubmed-author:GraesslinOO, pubmed-author:LagonotteEE, pubmed-author:LechkiCC, pubmed-author:LorenzatoMM, pubmed-author:MuiñoJ PJP, pubmed-author:PoletteMM, pubmed-author:QuereuxCC, pubmed-author:RigaudCC, pubmed-author:SarteletHH
pubmed:issnType	Print
pubmed:volume	58
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	864-71
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:16049291-Adult, pubmed-meshheading:16049291-Aged, pubmed-meshheading:16049291-Aged, 80 and over, pubmed-meshheading:16049291-Breast Neoplasms, pubmed-meshheading:16049291-Carcinoma, Ductal, pubmed-meshheading:16049291-Female, pubmed-meshheading:16049291-Genes, erbB-2, pubmed-meshheading:16049291-Humans, pubmed-meshheading:16049291-Immunoenzyme Techniques, pubmed-meshheading:16049291-In Situ Hybridization, pubmed-meshheading:16049291-In Situ Hybridization, Fluorescence, pubmed-meshheading:16049291-Middle Aged, pubmed-meshheading:16049291-Neoplasm Proteins, pubmed-meshheading:16049291-Prognosis, pubmed-meshheading:16049291-Prospective Studies, pubmed-meshheading:16049291-Receptor, erbB-2, pubmed-meshheading:16049291-Tumor Cells, Cultured, pubmed-meshheading:16049291-Tumor Markers, Biological
pubmed:year	2005
pubmed:articleTitle	Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma.
pubmed:affiliation	Laboratoire Pol Bouin, Centre Hospitalier et Universitaire de Reims, 45, Rue Cognacq-Jay, 51092 Reims Cedex, France. hsartelet@chu-reims.fr
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't

More...